Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 123.20%970K | 25.82%-2.27M | 62.02%-957K | 50.53%-9.06M | 132.03%707K | -15.95%-4.18M | 50.44%-3.06M | 60.10%-2.52M | 12.43%-18.31M | 65.84%-2.21M |
| Net income from continuing operations | 79.78%-542K | 33.98%-1.67M | 37.47%-3.44M | 2.74%-15.18M | 12.04%-4.49M | -358.04%-2.68M | 30.81%-2.52M | 30.49%-5.49M | 11.38%-15.61M | 5.35%-5.1M |
| Operating gains losses | 109.38%192K | 56.19%-641K | 56.64%1.62M | 45.47%-2.55M | 93.53%-66K | 54.55%-2.05M | 14.99%-1.46M | -60.01%1.03M | -62.61%-4.67M | 5.73%-1.02M |
| Depreciation and amortization | -56.00%33K | -13.48%77K | 21.59%107K | -11.35%336K | 746.15%84K | -39.02%75K | -29.92%89K | -38.03%88K | -23.59%379K | -112.50%-13K |
| Remuneration paid in stock | -75.00%5K | -88.89%7K | -91.34%11K | -33.14%236K | -83.85%26K | -80.00%20K | -64.20%63K | 251.19%127K | -67.73%353K | -46.33%161K |
| Other non cashItems | -156.88%-364K | -66.82%289K | -26.14%732K | 25.73%3.21M | -66.35%708K | 242.86%640K | 146.74%871K | 82.17%991K | 7,194.29%2.55M | 11,788.89%2.1M |
| Change In working capital | 880.32%1.47M | -233.33%-340K | -98.23%13K | 470.23%4.89M | 167.37%4.44M | -323.81%-188K | 93.08%-102K | 146.23%736K | 35.67%-1.32M | 541.76%1.66M |
| -Change in receivables | 4,928.57%1.01M | -125.24%-714K | 44.63%-67K | 169.43%714K | 530.65%1.17M | -106.34%-21K | -127.93%-317K | 91.28%-121K | 122.59%265K | 994.12%186K |
| -Change in inventory | 94.85%530K | 82,100.00%822K | 381.92%853K | 268.19%2.58M | 66.28%2.13M | 4,633.33%272K | 100.11%1K | 109.36%177K | -50.10%-1.53M | 245.56%1.28M |
| -Change in payables and accrued expense | 82.46%-77K | -309.35%-448K | -213.68%-773K | 3,059.26%1.6M | 480.20%1.14M | -82.16%-439K | 112.62%214K | -59.67%680K | -138.30%-54K | -59.38%197K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 123.20%970K | 25.82%-2.27M | 62.02%-957K | 50.53%-9.06M | 132.03%707K | -15.95%-4.18M | 50.44%-3.06M | 60.10%-2.52M | 12.43%-18.31M | 65.84%-2.21M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -1K | -100.08%-1K | -70.30%352K | 340.50%2.71M | 114.93%273K | 0 | 125,100.00%1.25M | 177.52%1.19M | -762.35%-1.13M | -262.72%-1.83M |
| Net PPE purchase and sale | --0 | --0 | 217.74%73K | ---62K | --0 | --0 | --0 | ---62K | --0 | --0 |
| Net investment purchase and sale | --0 | --0 | --0 | 264.25%2.06M | 100.95%19K | --0 | 2,322.86%778K | 181.33%1.27M | -468.33%-1.26M | -268.54%-2.01M |
| Net other investing changes | ---1K | -100.21%-1K | 1,568.42%279K | 443.85%707K | 41.11%254K | --0 | 1,288.24%472K | 17.39%-19K | 1,281.82%130K | 680.65%180K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---1K | -100.08%-1K | -70.30%352K | 340.50%2.71M | 114.93%273K | --0 | 125,100.00%1.25M | 177.52%1.19M | -762.35%-1.13M | -262.72%-1.83M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -108.20%-203K | -64.78%472K | 3,768.57%1.35M | -49.89%3.73M | -102.70%-121K | -20.77%2.48M | 1,388.46%1.34M | 158.33%35K | -36.32%7.44M | -14.81%4.48M |
| Net issuance payments of debt | -108.20%-203K | -62.06%472K | 1,802.00%851K | -64.35%1.07M | -3,053.41%-2.6M | -20.77%2.48M | 1,284.76%1.24M | 51.92%-50K | -39.26%3M | -98.33%88K |
| Net common stock issuance | --0 | --0 | --503K | -43.60%2.48M | --2.48M | --0 | --0 | --0 | -34.84%4.39M | ---- |
| Proceeds from stock option exercised by employees | --0 | --0 | --0 | 302.22%181K | --0 | --0 | 9,500.00%96K | 93.18%85K | --45K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -108.20%-203K | -64.78%472K | 3,768.57%1.35M | -49.89%3.73M | -102.70%-121K | -20.77%2.48M | 1,388.46%1.34M | 158.33%35K | -36.32%7.44M | -14.81%4.48M |
| Net cash flow | ||||||||||
| Beginning cash position | -91.80%69K | -84.06%215K | -98.40%47K | -79.88%2.93M | -87.67%375K | -72.46%841K | -84.17%1.35M | -79.88%2.93M | -36.81%14.56M | -78.60%3.04M |
| Current changes in cash | 144.93%766K | -301.34%-1.8M | 156.53%749K | 78.16%-2.62M | 92.60%859K | -735.78%-1.71M | 92.86%-449K | 77.72%-1.33M | -32.50%-11.99M | 694.67%446K |
| Effect of exchange rate changes | -161.58%-763K | 2,906.78%1.66M | -126.07%-581K | -173.13%-264K | -113.49%-1.19M | 548.69%1.24M | -107.21%-59K | -179.35%-257K | -36.56%361K | -229.91%-556K |
| End cash Position | -80.80%72K | -91.80%69K | -84.06%215K | -98.40%47K | -98.40%47K | -87.67%375K | -72.46%841K | -84.17%1.35M | -79.88%2.93M | -79.88%2.93M |
| Free cash from | 123.20%970K | 25.82%-2.27M | 62.94%-957K | 50.19%-9.12M | 132.03%707K | -15.95%-4.18M | 50.44%-3.06M | 59.11%-2.58M | 13.10%-18.31M | 66.03%-2.21M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.